Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jennifer Evans Stacey currently holds 25,000 shares of Context Therapeutics Inc. (CNTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer Evans Stacey has been a net seller of CNTX stock. They have purchased $0 and sold $745.1K worth of shares.
Jennifer Evans Stacey's most recent insider trade was on Jun 13, 2024, when they sold 25,000 shares at $0.00 per share.
Jennifer Evans Stacey serves as Executive at Context Therapeutics Inc. (CNTX). They have executed 24 insider transactions totaling $745.1K over their tenure at the company.
Jennifer Evans Stacey holds the position of Executive at Context Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Jennifer Evans Stacey has shown a selling trading pattern, with $0 in total purchases and $745.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jennifer Evans Stacey was on Sep 14, 2009, when they sold $224.4K worth of AUXL shares. This transaction involved 6,333 shares at $35.43 per share.
Jennifer Evans Stacey currently owns 25,000 shares of Context Therapeutics Inc. (CNTX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jennifer Evans Stacey's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jennifer Evans Stacey has 24 Form 4 filings on record as an insider at Context Therapeutics Inc..
Set alerts for Jennifer Evans Stacey and 40,000+ other insiders.